Description
MICROBIOLOGY SUPPLIES
First action · last action
2026-09-14 · 2026-09-14
Transactions
1
First transaction's obligation
$10,342
Base + all options value (sum of deltas)
$10,342
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
—
Offers received
—
SDVOSB flag on record
No
Parent IDV
36C25522A0044
NAICS
325413 · IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING
Modification chain · 1 transaction
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2026-09-14+$10,342= $10,342
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2026-09-14 | +$10,342 | $10,342 | MICROBIOLOGY SUPPLIES |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI F5TEGZ32EJ38)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C25926N0509 | NETWORK CONTRACT OFFICE 19 (36C259) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $773,691 | FY2026 |
| 36C25026P1145 | 250-NETWORK CONTRACT OFFICE 10 (36C250) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $20,028 | FY2026 |
| 36C25526N0441 | 255-NETWORK CONTRACT OFFICE 15 (36C255) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $15,850 | FY2026 |
| 36C25526N0437 | 255-NETWORK CONTRACT OFFICE 15 (36C255) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $13,194 | FY2026 |
| 36C25526N0408 | 255-NETWORK CONTRACT OFFICE 15 (36C255) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $59,553 | FY2026 |
| 36C25526N0439 | 255-NETWORK CONTRACT OFFICE 15 (36C255) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $50,698 | FY2026 |
Other recipients under 6550 from 255-NETWORK CONTRACT OFFICE 15 (36C255) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C25526N0405 | FISHER SCIENTIFIC COMPANY L.L.C. | 255-NETWORK CONTRACT OFFICE 15 (36C255) | $113,611 | FY2026 |
| 36C25526N0337 | CEPHEID | 255-NETWORK CONTRACT OFFICE 15 (36C255) | $2,571,141 | FY2026 |
| 36C25526N0307 | WERFEN USA LLC | 255-NETWORK CONTRACT OFFICE 15 (36C255) | $76,810 | FY2026 |
| 36C25526A0030 | QUIDELORTHO SALES COMPANY, LLC | 255-NETWORK CONTRACT OFFICE 15 (36C255) | $0 | FY2026 |
| 36C25526N0312 | QUIDELORTHO SALES COMPANY, LLC | 255-NETWORK CONTRACT OFFICE 15 (36C255) | $21,363 | FY2026 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C25526N0440_3600_36C25522A0044_3600 · retrieved 2026-09-27.